Page last updated: 2024-09-05

anidulafungin and amphotericin b

anidulafungin has been researched along with amphotericin b in 91 studies

Compound Research Comparison

Studies (anidulafungin)	Trials (anidulafungin)	Recent Studies (post-2010) (anidulafungin)	Studies (amphotericin b)	Trials (amphotericin b)	Recent Studies (post-2010) (amphotericin b)
568	33	331	17,210	673	4,294

Research

Studies (91)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	6 (6.59)	18.2507
2000's	32 (35.16)	29.6817
2010's	40 (43.96)	24.3611
2020's	13 (14.29)	2.80

Authors

Authors	Studies
Alastruey-Izquierdo, A; Almirante, B; Cuenca-Estrella, M; Gomez-Lopez, A; Pahissa, A; Rodriguez, D; Rodriguez-Tudela, JL	1
Chapman, SW; Cleary, JD; Garcia-Effron, G; Perlin, DS	1
Jacobson, MJ; Nguyen, G; Patel, R; Piper, KE; Steckelberg, JM	1
Chu, CC; Hsueh, PR; Ruan, SY	1
Alastruey-Izquierdo, A; Castelli, MV; Cuenca-Estrella, M; Cuesta, I; Mellado, E; Monzon, A; Rodriguez-Tudela, JL	1
Alastruey-Izquierdo, A; Cuenca-Estrella, M; Lass-Flörl, C; Perkhofer, S; Rodriguez-Tudela, JL	1
Arendrup, MC; Bruun, B; Buzina, W; Garcia-Effron, G; Jensen, HE; Lass-Flörl, C; Lundin, C; Mortensen, KL; Perlin, DS; Reiter, N	1
Dimopoulos, G; Falagas, ME; Velegraki, A	1
Chen, E; Ostrosky-Zeichner, L; Paetznick, VL; Rodriguez, J; Sheehan, DJ	1
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL	1
Chittick, P; Delashmitt, B; Evans, J; Palavecino, EL; Peacock, JE	1
Badali, H; De Hoog, GS; Illnait-Zaragozi, MT; Meis, JF; Najafzadeh, MJ	1
Alastruey-Izquierdo, A; Cuenca-Estrella, M; Cuesta, I; Rodriguez-Tudela, JL; Walther, G	1
Andes, DR; Crawford, K; Marchillo, K; Nett, JE	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Liu, W; Wang, S; Yuan, L	1
Arikan, S; Cetinkaya, Y; Kocagöz, S; Unal, S; Uzun, O	1
Denning, DW; Morrissey, G; Morrissey, J; Oakley, KL; Verweij, PE	1
Denning, DW; Moore, CB; Oakley, KL	2
Jones, RN; Marco, F; Messer, SA; Pfaller, MA	1
Bacher, J; Bell, A; Callender, DP; Groll, AH; McMillian, CL; Petraitiene, R; Petraitis, V; Schaufele, RL; Sein, T; Walsh, TJ	1
Bacher, J; Bell, A; Candelario, M; Groll, AH; Lyman, CA; McMillian, CL; Petraitiene, R; Petraitis, V; Sein, T; Walsh, TJ	1
Ernst, EJ; Klepser, ME; Pfaller, MA	1
Cuenca-Estrella, M; Díaz-Guerra, TM; Mellado, E; Monzón, A; Rodríguez-Tudela, JL	1
Bacher, J; Francesconi, A; Groll, AH; Lyman, CA; Petraitiene, R; Petraitis, V; Piscitelli, SC; Schaufele, RL; Sein, T; Walsh, TJ	1
de Pauw, B	1
Bernal, S; Chávez M, M; Claro, RM; Martín-Mazuelos, E; Pemán, J; Ramirez, M; Serrano, Mdel C; Valverde-Conde, A	1
Chen, E; Odabasi, Z; Ostrosky-Zeichner, L; Paetznick, VL; Rodriguez, JR	1
Steinbach, WJ	1
Chen, E; Odabasi, Z; Ostrosky-Zeichner, L; Paetznick, VL; Philip, A; Rex, JH; Rodriguez, J	1
Goldstein, BP; Hoban, DJ; Karlowsky, JA; Zhanel, GG	1
Deziel, MR; Drusano, GL; Drusano, MF; Gumbo, T; Liu, W; Louie, A; Ma, L	1
Graninger, W; Joukhadar, C; Presterl, E; Wagner, C	1
Cantón, E; Pemán, J; Quindós, G; Valentín, A	1
Edwards, JE; Fu, Y; Gebremariam, T; Ibrahim, AS; Spellberg, B	1
Kang, CI; Mandrekar, JN; Patel, R; Rouse, MS; Steckelberg, JM	1
Cooper, C; Mills, EJ; Nachega, JB; Perri, D; Phillips, P; Tleyjeh, I; Wu, P	1
Borges Sá, M; Garnacho Montero, J	1
Ruiz Camps, I; Vázquez López, L	1
Gadea, I; Mensa, J	1
Barchiesi, F; Loretelli, C; Manso, E; Milici, ME; Orlando, F; Pisa, E; Santinelli, A; Scalise, G; Spreghini, E	1
Benner, KW; Prabhakaran, P; Varisco, BM	1
Arnold, TM; Dotson, E; Hage, CA; Sarosi, GA	1
Aznar, J; de Toro, M; Maite, R; Torres, MJ	1
Andes, D; Bastulli, C; Chaturvedi, V; Diekema, DJ; Ghannoum, MA; Iqbal, N; Knapp, C; Lockhart, SR; Marchillo, K; Messer, S; Ostrosky-Zeichner, L; Paetznick, VL; Pfaller, MA; Ramani, R; Rodriguez, J; Sein, T; Walsh, TJ; Welshenbaugh, AR	1
Castanheira, M; Diekema, DJ; Duncanson, FP; Guarro, J; Jones, RN; Pfaller, MA	1
Alves, SH; Antunes, MS; Bandeira, LA; Denardi, LB; Mario, DA; Santurio, JM; Severo, LC	1
Caggiano, G; Carone, A; Corbo, F; Franchini, C; Montagna, MT; Muraglia, M; Piarulli, M; Rosato, A; Schiavone, BI	1
Drogari-Apiranthitou, M; Grammatikou, M; Kanioura, L; Mantopoulou, FD; Mitroussia-Ziouva, A; Petrikkos, G; Skiada, A; Tsakris, A; Vrioni, G	1
Cantón, E; Monteiro-Soares, M; Moreira-Rosário, A; Pina-Vaz, C; Rocha, R; Rodrigues, AG; Teixeira-Santos, R	1
Chen, HT; Chu, WL; Lin, CC; Lo, HJ; Yang, YL	1
Brock, M; Galiger, C; Ibrahim-Granet, O; Jouvion, G; Parlato, M; Savers, A	1
Capilla, J; Fernández-Silva, F; Guarro, J; Hernández, P; Mayayo, E; Sutton, DA	1
Capilla, J; Fernández-Silva, F; Guarro, J; Mayayo, E; Sutton, D	1
Borens, O; Furustrand Tafin, U; Maiolo, EM; Trampuz, A	1
Kyrpitzi, D; Roilides, E; Simitsopoulou, M; Velegraki, A; Walsh, TJ	1
Badali, H; de Hoog, GS; Mashedi, O; Meis, JF; Mohammadi, R	1
Chlebicki, MP; Kwa, AL; Lee, W; Liew, YX; Ngan, CC; Tan, AL; Teo, J; Too, IA	1
Basak, A; Chakraborty, A; Chakraborty, R; Franco, OL; Hazra, TK; Hossain, M; Mahata, D; Mandal, SM; Mukhopadhyay, CK; Porto, WF	1
Badali, H; Chowdhary, A; de Hoog, GS; Fakhim, H; Khodavaisy, S; Meis, JF	1
Baumgarten, G; Bode, C; Boehm, O; Diedrich, B; Frede, S; Hoeft, A; Jahnert, S; Knuefermann, P; Meyer, R; Muenster, S; Steinhagen, F; Weisheit, C	1
Gökbolat, E; Ilkit, M; Kiraz, N; Öz, Y; Özdemir, HG; Seyedmousavi, S	1
Bouza, E; Escribano, P; Gómez-Perosanz, M; Guinea, J; Marcos-Zambrano, LJ; Zaragoza, O	1
Arslan, U; Dagi, HT; Findik, D; Senkeles, C	1
Legendre, DP; Muzny, CA; Riley, TT; Swiatlo, E	1
Cadirci, E; Duzgun, E; Karagoz, E; Keles, S; Turhan, V; Ugan, RA; Uyanik, MH; Yavan, I	1
Almirante, B; Basas, J; Del Pozo, JL; Gavaldà, J; Gomis, X; Martín, MT; Morer, A; Ratia, C; Rojo-Molinero, E; Torrents, E	1
Calvo, B; Colombo, AL; Francisco, EC; Hagen, F; Hernandez, M; Meis, JF; Melo, AS; Perozo-Mena, A	1
Capilla, J; Guarro, J; Martin-Vicente, A	1
Denis, J; Herbrecht, R; Ledoux, MP; Toussaint, E	1
Bellanger, AP; Cervoni, JP; Deconinck, E; Faucher, JF; Ginet, M; Grenouillet, F; Weil-Verhoeven, D	1
Agurto, C; Bustamante, B; Diaz, A; Hidalgo, J; Huaroto, L; Illescas, R; Ramirez, R; Rodriguez, L	1
Cai, WP; Chen, WS; Chen, XJ; He, Y; Hu, FY; Lei, HL; Li, LH; Song, WN; Tang, XP	1
Almirante, B; Basas, J; Gavaldà, J; Gomis, X; Palau, M	1
Eraso, E; Gil-Alonso, S; Jauregizar, N; Marcos-Arias, C; Mateo, E; Quindós, G; Sevillano, E	1
Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E	1
Chaftari, AM; Hachem, R; Kontoyiannis, DP; Raad, II; Reitzel, RA; Rosenblatt, J; Vargas-Cruz, N; Wilson Dib, R	1
Berrio, I; Dudiuk, C; Gamarra, S; Garcia-Effron, G; Leonardelli, F; Macedo, D; Marin, A; Morales-Lopez, S; Salcedo, S; Theill, L; Yesid-Rodriguez, J	1
Abastabar, M; Alastruey-Izquierdo, A; Hedayati, MT; Meletiadis, J; Nouripour-Sisakht, S; Rivero-Menendez, O; Sabino, R; Seyedmousavi, S; Siopi, M; Tavakoli, M; Valadan, R; van der Lee, H; Yazdani Charati, J; Zarrinfar, H	1
Borman, AM; Fraser, M; Johnson, EM; Muller, J; Palmer, MD; Patterson, Z; Szekely, A; Walsh-Quantick, J	1
Chen, J; Chu, Y; Han, X; Shang, H; Tian, S; Wang, Q; Zhou, B	1
Fuchs, F; Hamprecht, A; Hof, H; Hofmann, S; Kurzai, O; Meis, JF	1
Farooqi, J; Jabeen, K; Memon, S; Naqvi, SF; Zafar, A; Zafar, U	1
Abastabar, M; Aghili, SR; Badali, H; Haghani, I; Hedayati, MT; Javidnia, J; Khojasteh, S; Meis, JF; Moazeni, M; Nargesi, S; Nosratabadi, M; Shabanzadeh, S; Shokohi, T; Zaedi, A	1
Bilal, H; Hou, B; Islam, R; Khan, MN; Khan, RU; Shafiq, M; Zeng, Y	1
Balázs, B; Balogh, B; Bozó, A; Forgács, L; Kelentey, B; Kovács, R; Majoros, L; Tóth, Z	1
Gonçalves, GA; Kraft, L; Ribeiro, VST; Suss, PH; Tuon, FF	1
Mosegui, GBG; Rodrigues, MPDS; Vianna, CMM	1
Enersen, M; Fjeld, KG; Gay, CL; Herlofson, BB; Hove, LH; Kristoffersen, AK; Lerdal, A; Monsen, RE; Nordgarden, H; Tollisen, A	1
Abastabar, M; Badiee, P; Haghani, I; Mohammadi, R; Morovati, H; Noorbakhsh, M; Sharifi, M	1

Reviews

14 review(s) available for anidulafungin and amphotericin b

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall. Journal of medicinal chemistry, 2020, 11-12, Volume: 63, Issue:21 Topics: Antifungal Agents; Cell Wall; Drug Discovery; Fungi; GPI-Linked Proteins; Humans; Mannans; Mycoses; Triterpenes	2020
Is there a need for new antifungal agents? Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2000, Volume: 6 Suppl 2 Topics: Amphotericin B; Anidulafungin; Animals; Anti-Bacterial Agents; Antifungal Agents; Echinocandins; Fungal Proteins; Humans; Mycoses; Peptides; Peptides, Cyclic	2000
Antifungal agents in children. Pediatric clinics of North America, 2005, Volume: 52, Issue:3 Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole	2005
The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications. Pharmacology, 2006, Volume: 78, Issue:4 Topics: Actins; Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Candidiasis; Caspofungin; Drug Resistance, Microbial; Echinocandins; Humans; Lipopeptides; Lipoproteins; Liver; Liver Failure; Micafungin; Models, Chemical; Peptides, Cyclic; Rats	2006
Antifungal treatment for invasive Candida infections: a mixed treatment comparison meta-analysis. Annals of clinical microbiology and antimicrobials, 2009, Jun-26, Volume: 8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candidiasis; Echinocandins; Fluconazole; Humans; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult	2009
[Role of anidulafungin in critically ill patients]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 14 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Critical Illness; Cross Infection; Drug Therapy, Combination; Echinocandins; Fluconazole; Fungemia; Humans; Immunocompetence; Intensive Care Units; Itraconazole; Practice Guidelines as Topic	2008
[Potential of anidulafungin in hematological patients]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 14 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Azoles; Candidiasis; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Therapy, Combination; Echinocandins; Fungemia; Hematologic Diseases; Hematologic Neoplasms; Humans; Inactivation, Metabolic; Kidney Diseases; Liver Diseases; Mice; Neutropenia; Risk Factors	2008
[Potential of anidulafungin in combined therapy]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 14 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Azoles; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Echinocandins; Encephalomyelitis; Fungemia; Guinea Pigs; Humans; Lung Diseases, Fungal; Mice; Mycoses	2008
Traditional and emerging antifungal therapies. Proceedings of the American Thoracic Society, 2010, Volume: 7, Issue:3 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole	2010
Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options. The Annals of pharmacotherapy, 2016, Volume: 50, Issue:9 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Debridement; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Mucorales; Mucormycosis; Nitriles; Pyridines; Triazoles; Virulence	2016
Therapeutic tools for oral candidiasis: Current and new antifungal drugs. Medicina oral, patologia oral y cirugia bucal, 2019, Mar-01, Volume: 24, Issue:2 Topics: Administration, Intravenous; Administration, Oral; Administration, Topical; Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candidiasis, Oral; Caspofungin; Clotrimazole; Databases, Factual; Drug Interactions; Echinocandins; Fluconazole; Humans; Miconazole; Nitriles; Nystatin; Pyridines; Triazoles	2019
Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris. BMC infectious diseases, 2020, Nov-11, Volume: 20, Issue:1 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Multiple, Fungal; Fluconazole; Humans; Micafungin; Prevalence	2020
Distribution and antifungal susceptibility pattern of Virulence, 2022, Volume: 13, Issue:1 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Candidiasis; Echinocandins; Fluconazole; Humans; Microbial Sensitivity Tests	2022

Other Studies

77 other study(ies) available for anidulafungin and amphotericin b

Article	Year
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Spain; Species Specificity	2008
Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6 Topics: Aged; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fatal Outcome; Female; Fungal Proteins; Fungemia; Glucosyltransferases; Humans; Lipopeptides; Membrane Proteins; Microbial Sensitivity Tests; Mutation	2008
In vitro activity of anidulafungin against Candida albicans biofilms. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6 Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests	2008
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8 Topics: Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2008
Susceptibility testing and molecular classification of Paecilomyces spp. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8 Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; Echinocandins; Itraconazole; Microbial Sensitivity Tests; Paecilomyces; Phylogeny	2008
In vitro activities of various antifungal drugs against Aspergillus terreus: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2 Topics: Antifungal Agents; Aspergillosis; Aspergillus; DNA, Fungal; Humans; Microbial Sensitivity Tests; Soil Microbiology	2009
Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Caspofungin; Colony Count, Microbial; Echinocandins; Humans; Immunohistochemistry; Injections, Intraperitoneal; Lipopeptides; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Polymerase Chain Reaction	2009
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3 Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies	2009
Activity of anidulafungin in a murine model of Candida krusei infection: evaluation of mortality and disease burden by quantitative tissue cultures and measurement of serum (1,3)-beta-D-glucan levels. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:4 Topics: Anidulafungin; Animals; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Disease Models, Animal; Echinocandins; Kidney; Male; Mice	2009
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5 Topics: Acremonium; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Penicillium; Scedosporium; Spain	2009
Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Aged; Antifungal Agents; Echinocandins; Fatal Outcome; Geotrichosis; Geotrichum; Humans; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Neutropenia	2009
In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:4 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole	2010
Antifungal susceptibility profile of human-pathogenic species of Lichtheimia. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7 Topics: Amphotericin B; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mucorales; Pyrimidines; Triazoles; Voriconazole	2010
Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:8 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida albicans; Drug Resistance, Fungal; Echinocandins; Flucytosine; Fungal Proteins; Glucans; Glucosyltransferases; Humans; Microbial Sensitivity Tests; Polyenes; Pyrimidines	2010
In vitro activity of a new echinocandin, LY303366, compared with those of amphotericin B and fluconazole against clinical yeast isolates. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:5 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Echinocandins; Fluconazole; Microbial Sensitivity Tests; Peptides, Cyclic	1997
Efficacy of LY303366 against amphotericin B-susceptible and -resistant Aspergillus fumigatus in a murine model of invasive aspergillosis. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:4 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Colony Count, Microbial; Cyclophosphamide; Drug Resistance, Microbial; Echinocandins; Immunocompromised Host; Immunosuppressive Agents; Male; Mice; Microbial Sensitivity Tests; Neutropenia; Peptides, Cyclic	1998
In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:10 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus; Echinocandins; Itraconazole; Microbial Sensitivity Tests; Peptides, Cyclic	1998
Activity of MK-0991 (L-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp. Diagnostic microbiology and infectious disease, 1998, Volume: 32, Issue:1 Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Blood; Candida; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Peptides; Peptides, Cyclic; Sensitivity and Specificity; Serum Bactericidal Test	1998
Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:11 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Dose-Response Relationship, Drug; Echinocandins; Female; Lung Diseases, Fungal; Neutropenia; Peptides, Cyclic; Rabbits	1998
Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:9 Topics: Amphotericin B; Analysis of Variance; Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Creatinine; Dose-Response Relationship, Drug; Echinocandins; Female; Fluconazole; Metabolic Clearance Rate; Microbial Sensitivity Tests; Neutropenia; Peptides, Cyclic; Potassium; Rabbits	1999
Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:4 Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Azoles; Candida albicans; Caspofungin; Cryptococcus neoformans; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Polyenes	2000
Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B. The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:3 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Echinocandins; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Peptides, Cyclic	2000
Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:2 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candidiasis; Candidiasis, Oral; Drug Resistance, Microbial; Echinocandins; Esophageal Diseases; Esophagus; Female; Fluconazole; Immunosuppression Therapy; Peptides, Cyclic; Pharyngeal Diseases; Rabbits; Saliva	2001
In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2001, Volume: 7, Issue:1 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Culture Media; Echinocandins; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Peptides, Cyclic; Reproducibility of Results	2001
In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus spp. Diagnostic microbiology and infectious disease, 2003, Volume: 45, Issue:2 Topics: Amphotericin B; Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Time Factors; Triazoles; Voriconazole	2003
In vitro activity of anidulafungin against selected clinically important mold isolates. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:5 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Echinocandins; Fungi; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2004
In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:8 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus; Drug Synergism; Echinocandins; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2005
In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species. International journal of antimicrobial agents, 2006, Volume: 27, Issue:2 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Interactions; Echinocandins; Flucytosine; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Peptides, Cyclic	2006
Anidulafungin pharmacokinetics and microbial response in neutropenic mice with disseminated candidiasis. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:11 Topics: Algorithms; Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Candida glabrata; Candidiasis; Colony Count, Microbial; Dose-Response Relationship, Drug; Echinocandins; Female; Fluconazole; Mice; Microbial Sensitivity Tests; Neutropenia; Peptides, Cyclic	2006
[In vitro activity of amphotericin B and anidulafungin against Candida spp. biofilms]. Revista iberoamericana de micologia, 2007, Dec-31, Volume: 24, Issue:4 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida albicans; Candida tropicalis; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Echinocandins; Microbial Sensitivity Tests; Species Specificity	2007
Combination echinocandin-polyene treatment of murine mucormycosis. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lipoproteins; Liposomes; Male; Micafungin; Mice; Mice, Inbred BALB C; Mucormycosis; Polyenes; Rhizopus; Treatment Outcome	2008
Anidulafungin treatment of candidal central nervous system infection in a murine model. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Central Nervous System Infections; Disease Models, Animal; Echinocandins; Female; Mice; Pyrimidines; Triazoles; Voriconazole	2009
Anidulafungin in combination with amphotericin B against Aspergillus fumigatus. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:9 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Drug Therapy, Combination; Echinocandins; Kidney; Mice; Microbial Sensitivity Tests	2009
Neonatal peritoneal candidiasis successfully treated with anidulafungin add-on therapy. The Annals of pharmacotherapy, 2009, Volume: 43, Issue:11 Topics: Amphotericin B; Anidulafungin; Candidiasis; Drug Therapy, Combination; Echinocandins; Female; Humans; Infant, Newborn; Peritoneal Cavity; Treatment Outcome	2009
Characterization of Candida parapsilosis complex isolates. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2011, Volume: 17, Issue:3 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida; Candidemia; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests; Pyrimidines; Random Amplified Polymorphic DNA Technique; Triazoles; Voriconazole	2011
Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Drug Combinations; Echinocandins; Enzyme-Linked Immunosorbent Assay; Inhibitory Concentration 50; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2011
Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1 Topics: Acylation; Aminopyridines; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Fusarium; Glycosylphosphatidylinositols; Humans; Inositol; Isoxazoles; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Scedosporium; Triazoles; Voriconazole	2012
The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates. Memorias do Instituto Oswaldo Cruz, 2012, Volume: 107, Issue:3 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2012
In vitro synergy testing of anidulafungin with fluconazole, tioconazole, 5-flucytosine and amphotericin B against some Candida spp. Medicinal chemistry (Shariqah (United Arab Emirates)), 2012, Volume: 8, Issue:4 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Drug Synergism; Echinocandins; Fluconazole; Flucytosine; Imidazoles	2012
In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:8 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Drug Synergism; Echinocandins; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles	2012
Novel method for evaluating in vitro activity of anidulafungin in combination with amphotericin B or azoles. Journal of clinical microbiology, 2012, Volume: 50, Issue:8 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Barbiturates; Candida; Drug Synergism; Echinocandins; Flow Cytometry; Fluorescence; Fluorescent Dyes; Humans; Isoxazoles; Microbial Sensitivity Tests; Sensitivity and Specificity; Staining and Labeling	2012
Species distribution and drug susceptibilities of Candida isolates in TSARY 2010. Diagnostic microbiology and infectious disease, 2013, Volume: 76, Issue:2 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candida; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Hospitals; Humans; Microbial Sensitivity Tests; Pyrimidines; Taiwan; Triazoles; Voriconazole	2013
Assessment of efficacy of antifungals against Aspergillus fumigatus: value of real-time bioluminescence imaging. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Echinocandins; Luminescent Measurements; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2013
Evaluation of the efficacies of Amphotericin B, Posaconazole, Voriconazole, and Anidulafungin in a murine disseminated infection by the emerging opportunistic Fungus Sarocladium (Acremonium) kiliense. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12 Topics: Acremonium; Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Echinocandins; Male; Mice; Mycoses; Pyrimidines; Triazoles; Voriconazole	2013
In vitro evaluation of antifungal drug combinations against Sarocladium (Acremonium) kiliense, an opportunistic emergent fungus resistant to antifungal therapies. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2 Topics: Acremonium; Amphotericin B; Anidulafungin; Antifungal Agents; Drug Combinations; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Humans; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole	2014
Activities of fluconazole, caspofungin, anidulafungin, and amphotericin B on planktonic and biofilm Candida species determined by microcalorimetry. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:5 Topics: Amphotericin B; Anidulafungin; Biofilms; Calorimetry; Candida; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests; Plankton	2014
Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida; Candida albicans; Caspofungin; Catheters; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Plankton	2014
In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs. Mycoses, 2015, Volume: 58, Issue:5 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Epidermophyton; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Nitriles; Pyridines; Terbinafine; Tinea; Triazoles; Trichophyton; Voriconazole	2015
Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution. BMC infectious diseases, 2015, Jul-03, Volume: 15 Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; beta-Glucans; Candida; Candida albicans; Candida glabrata; Candidiasis; Candidiasis, Invasive; Carrier State; Caspofungin; Critical Care; Echinocandins; Female; Fluconazole; Humans; Incidence; Intensive Care Units; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Sensitivity and Specificity; Singapore; Tertiary Care Centers; Voriconazole	2015
Amphotericin B and anidulafungin directly interact with DNA and induce oxidative damage in the mammalian genome. Molecular bioSystems, 2015, Volume: 11, Issue:9 Topics: Amphotericin B; Anidulafungin; Animals; Calorimetry; Circular Dichroism; DNA; DNA Damage; Echinocandins; Genome; Mammals; Molecular Conformation; Molecular Docking Simulation; Oxidative Stress; Thermodynamics	2015
In Vitro Susceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole	2015
Antifungal antibiotics modulate the pro-inflammatory cytokine production and phagocytic activity of human monocytes in an in vitro sepsis model. Life sciences, 2015, Nov-15, Volume: 141 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Cells, Cultured; Cytokines; Echinocandins; Gene Expression; Humans; Immunosuppressive Agents; Inflammation; Itraconazole; Monocytes; Phagocytosis; Sepsis	2015
Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses. Mycopathologia, 2016, Volume: 181, Issue:3-4 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Eye; Eye Infections, Fungal; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Triazoles; Voriconazole	2016
Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Glucosyltransferases; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2016
Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey. Annals of clinical microbiology and antimicrobials, 2016, May-31, Volume: 15, Issue:1 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Species Specificity; Triazoles; Voriconazole	2016
A Comparative Study of the Effects of Intravitreal Anidulafungin, Voriconazole, and Amphotericin B in an Experimental Candida Endophthalmitis Model. Current eye research, 2017, Volume: 42, Issue:2 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Conjunctiva; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Intravitreal Injections; Iris; Male; Rabbits; Vitreous Body; Voriconazole	2017
Efficacy of anidulafungin in the treatment of experimental Candida parapsilosis catheter infection using an antifungal-lock technique. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:10 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Biofilms; Candida; Candidiasis; Catheter-Related Infections; Catheters, Indwelling; Echinocandins; Male; Microbial Sensitivity Tests; Rabbits; Silicones	2016
First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia. The Journal of infection, 2016, Volume: 73, Issue:4 Topics: Adult; Aged; Americas; Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Anidulafungin; Antifungal Agents; Azoles; Candida; Candidemia; Cross Infection; Disease Outbreaks; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Female; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Venezuela; Young Adult	2016
Does a triple combination have better activity than double combinations against multiresistant fungi? Experimental in vitro evaluation. International journal of antimicrobial agents, 2017, Volume: 49, Issue:4 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Ascomycota; Drug Synergism; Echinocandins; Voriconazole	2017
New pharmacological opportunities for the treatment of invasive mould diseases. The Journal of antimicrobial chemotherapy, 2017, 03-01, Volume: 72, Issue:suppl_1 Topics: Amphotericin B; Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Echinocandins; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Triazoles; Voriconazole	2017
Paecilomyces variotii Fungemia in a Patient with Lymphoma Needing Liver Transplant. Mycopathologia, 2017, Volume: 182, Issue:7-8 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Echinocandins; Fungemia; Hepatic Insufficiency; Humans; Liver Transplantation; Lymphoma; Male; Middle Aged; Paecilomyces	2017
A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes. PloS one, 2017, Volume: 12, Issue:4 Topics: Adolescent; Adult; Aged; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidemia; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Incidence; Infant; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Peru; Prospective Studies; Triazoles; Voriconazole; Young Adult	2017
Susceptibility profile of echinocandins, azoles and amphotericin B against yeast phase of Talaromyces marneffei isolated from HIV-infected patients in Guangdong, China. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018, Volume: 37, Issue:6 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Echinocandins; HIV Infections; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Reagent Kits, Diagnostic; Talaromyces; Voriconazole	2018
Efficacy of liposomal amphotericin B and anidulafungin using an antifungal lock technique (ALT) for catheter-related Candida albicans and Candida glabrata infections in an experimental model. PloS one, 2019, Volume: 14, Issue:2 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Biofilms; Candida; Candida albicans; Candida glabrata; Candidiasis; Catheter-Related Infections; Catheters; Models, Theoretical; Rabbits	2019
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia. Scientific reports, 2019, 03-07, Volume: 9, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult	2019
Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective for Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:7 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida; Caspofungin; Catheter-Related Infections; Catheters; Citric Acid; Ethanol; Fluconazole; Micafungin; Nitroglycerin; Pharmaceutical Solutions; Voriconazole	2019
Antifungal activity and killing kinetics of anidulafungin, caspofungin and amphotericin B against Candida auris. The Journal of antimicrobial chemotherapy, 2019, 08-01, Volume: 74, Issue:8 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Caspofungin; Microbial Sensitivity Tests; Microbial Viability; Time Factors	2019
Genetic diversity and antifungal susceptibility patterns of Aspergillus nidulans complex obtained from clinical and environmental sources. Mycoses, 2020, Volume: 63, Issue:1 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Aspergillus nidulans; Azoles; Cross Infection; Environmental Microbiology; Genetic Variation; Greece; Humans; Iran; Micafungin; Microbial Sensitivity Tests; Microsatellite Repeats; Molecular Epidemiology; Netherlands; Phylogeny; Phylogeography; Portugal; Spain; Tubulin	2020
MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution method. The Journal of antimicrobial chemotherapy, 2020, 05-01, Volume: 75, Issue:5 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; United Kingdom; Voriconazole	2020
Antifungal activity of nitroxoline against Candida auris isolates. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2021, Volume: 27, Issue:11 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida auris; Fluconazole; Humans; Microbial Sensitivity Tests; Nitroquinolines	2021
Antifungal susceptibility profile of invasive Journal of medical microbiology, 2021, Volume: 70, Issue:12 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida glabrata; Candidemia; Caspofungin; Cross-Sectional Studies; Drug Resistance, Fungal; Fluconazole; Humans; Micafungin; Pakistan; Retrospective Studies; Tertiary Care Centers	2021
In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates. Mycoses, 2022, Volume: 65, Issue:11 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus oryzae; Clotrimazole; Econazole; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Natamycin; Nystatin; Terbinafine; Tolnaftate; Voriconazole	2022
The In Vitro Activity of Fluconazole, Amphotericin B and Echinocandins Against Cyberlindnera fabianii Planktonic Cells and Biofilms. Mycopathologia, 2023, Volume: 188, Issue:1-2 Topics: Amphotericin B; Anidulafungin; Biofilms; Caspofungin; Echinocandins; Fluconazole; Micafungin	2023
Comparison of amphotericin B lipid complex, deoxycholate amphotericin B, fluconazole, and anidulafungin activity against Candida albicans biofilm isolated from breakthrough candidemia. Enfermedades infecciosas y microbiologia clinica (English ed.), 2023, Volume: 41, Issue:10 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida; Candida albicans; Candidemia; Deoxycholic Acid; Fluconazole; Humans	2023
Cost-effectiveness analysis and budgetary impact of anidulafungin treatment for patients with candidemia and other forms of invasive candidiasis in Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo, 2023, Volume: 65 Topics: Anidulafungin; Brazil; Candidemia; Candidiasis, Invasive; Cost-Effectiveness Analysis; Humans	2023
Identification and susceptibility testing of oral candidiasis in advanced cancer patients. BMC oral health, 2023, 04-18, Volume: 23, Issue:1 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Neoplasms	2023
A 3-year study of Frontiers in cellular and infection microbiology, 2023, Volume: 13 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidemia; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Neoplasms	2023